Hematology/Oncology · Brooklyn, NY
NPI
1154380376
Since 2006
Specialty
Hematology/Oncology
Code 174400000X
Group practices
2
Medicare group memberships
Hospitals
1
Hospital affiliations
9920 4th Ave
Brooklyn, NY, 11209
Phone (718) 921-1672
Groups this clinician bills Medicare through
Medicare paid, 2024
$131K
2,017 services
Medicare patients, 2024
410
Average age 76
Drug cost, 2024
$2.5M
1,127 prescriptions
Company payments, 2025
$173
From 2 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Rami K Daya was code 99214 (office e&m - established), 949 times for 288 patients. In total Rami K Daya billed 2,017 services in 13 codes, and Medicare paid $131K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2021-03-22.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 949 | 288 | $92.39 | $88K |
| 36415 Venipuncture Blood Collection | Office | 722 | 342 | $8.64 | $6,237 |
| 99213 Office E&M - Established | Office | 168 | 123 | $70.24 | $12K |
| 99204 Office E&M - New | Office | 81 | 81 | $138.32 | $11K |
| 99215 Office E&M - Established | Office | 64 | 49 | $148.59 | $9,510 |
| 99205 Office E&M - New | Office | 14 | 14 | $187.44 | $2,624 |
By year: 2022 $122K for 1,830 services; 2023 $128K for 1,834 services; 2024 $131K for 2,017 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 722 | 342 | $8.64 | $6,237 |
Medicare prescription drug claims, 2024
In 2024, the drug Rami K Daya prescribed most often to Medicare patients was Acyclovir, with 73 prescriptions and refills. In total Rami K Daya wrote 1,127 Medicare prescriptions that cost $2.5M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Acyclovir Generic | 73 | 95 | 16 | $935 |
| Eliquis Apixaban | 63 | 69 | 13 | $35K |
| Anastrozole Generic | 52 | 98 | 14 | $526 |
| Ondansetron Hcl Generic | 51 | 51 | 19 | $832 |
| Prednisone Generic | 44 | 44 | 16 | $168 |
| Letrozole Generic | 38 | 110 | 14 | $793 |
| Xarelto Rivaroxaban | 34 | 44 | Under 11 | $25K |
| Imbruvica Ibrutinib | 32 | 32 | Under 11 | $541K |
| Potassium Chloride Generic | 32 | 40 | Under 11 | $278 |
| Allopurinol Generic | 32 | 43 | 11 | $212 |
| Omeprazole Generic | 30 | 36 | Under 11 | $386 |
| Neupogen Filgrastim | 30 | 30 | Under 11 | $34K |
| Dexamethasone Generic | 27 | 35 | 12 | $352 |
| Levofloxacin Generic | 25 | 25 | 20 | $42.11 |
| Loperamide Loperamide Hcl | 24 | 24 | Under 11 | $237 |
Brand drugs: 285 claims; generic drugs: 842 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Rami K Daya $173 ($173 in general payments such as food, travel and fees) from 2 companies. The largest payer was Heartflow, Inc. with $118.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.